Winston Medical Supply Co., Ltd. (TPEX:6817)
Taiwan · Delayed Price · Currency is TWD 48.85
-0.15 (-0.31%)
Aug 19, 2026, 1:25 PM CST
Winston Medical Supply Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 632.8 | 700.07 | 695.08 | 709.07 | 606.52 | 536.53 |
Revenue Growth | -9.61% | 0.72% | -1.97% | 16.91% | 13.05% | 6.22% |
Gross Profit Gross Profit Growth | 254.45 | 303.77 | 315.84 | 347.6 | 264.45 | 237.39 |
Operating Income Operating Income Growth | 97.55 | 141.82 | 159.26 | 196.1 | 135.86 | 115.29 |
Net Income Net Income Growth | 82.47 | 117.29 | 131.59 | 158.76 | 111.26 | 92.13 |
Earnings Per Share EPS Growth | 4.47 | 6.35 | 7.12 | 8.58 | 6.01 | 4.99 |
EPS Growth | -29.56% | -10.81% | -17.02% | 42.76% | 20.44% | -11.21% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Generic Medicine Excl. Health Food Generic Medicine Excl. Health Food Growth | 416.39 | 416.39 | 396.98 | 344.5 | 313 | 280.05 |
Medical Beauty Care Products Medical Beauty Care Products Growth | 283.69 | 283.69 | 298.1 | 332.5 | 231.24 | 205.36 |
Total Total Growth | 700.07 | 700.07 | 695.08 | 709.07 | 606.52 | 536.53 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 325.77 | 298.92 | 299.55 | 299.14 | 202.67 | 162.8 |
Total Debt Total Debt Growth | 44.36 | 48.16 | 56.06 | 63.92 | 62.12 | 68.15 |
Net Cash (Debt) Net Cash Growth | 281.41 | 250.76 | 243.5 | 235.22 | 140.56 | 94.65 |
Net Cash Growth | 12.22% | 2.98% | 3.52% | 67.35% | 48.50% | 1252.95% |
Net Cash Per Share Net Cash Per Share Growth | 15.25 | 13.57 | 13.17 | 12.72 | 7.60 | 5.13 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 119.25 | 154.97 | 148.09 | 215.45 | 124.88 | 146.46 |
Capital Expenditures CapEx Growth | -13.53 | -16.49 | -17.85 | -19.04 | -6.39 | -5.05 |
Free Cash Flow Free Cash Flow Growth | 105.72 | 138.49 | 130.24 | 196.41 | 118.49 | 141.4 |
Free Cash Flow Growth | -23.66% | 6.33% | -33.69% | 65.76% | -16.20% | 29.92% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.21% | 43.39% | 45.44% | 49.02% | 43.60% | 44.25% |
Operating Margin | 15.42% | 20.26% | 22.91% | 27.66% | 22.40% | 21.49% |
Pretax Margin | 16.39% | 20.87% | 23.62% | 28.04% | 23.31% | 21.73% |
Profit Margin | 13.03% | 16.75% | 18.93% | 22.39% | 18.34% | 17.17% |
FCF Margin | 16.71% | 19.78% | 18.74% | 27.70% | 19.54% | 26.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 7.000 | 6.600 | 5.000 | 4.000 |
Dividend Per Share Growth | -28.57% | -28.57% | 6.06% | 32.00% | 25.00% | 33.33% |
Dividend Yield | 10.20% | 6.58% | 8.88% | 8.23% | 10.48% | 7.33% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.05 | 12.95 | 12.78 | 11.39 | 10.23 | 14.85 |
P/FCF Ratio | 9.39 | 10.97 | 12.91 | 9.21 | 9.61 | 9.67 |
PS Ratio | 1.57 | 2.17 | 2.42 | 2.55 | 1.88 | 2.55 |